Peptide Referee

KLOW blend (GHK-Cu + KPV + BPC-157 + TB-500): research, legal status and who sells it

This page is information, not medical advice. KLOW blend (GHK-Cu + KPV + BPC-157 + TB-500) is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.

Also known as
KLOW, GHK-Cu, KPV, BPC-157 and TB-500 blend
Category
Blend of GHK-Cu, KPV, BPC-157 and TB-500
Evidence level
Preclinical (lab and animal studies)
Price range
$0.563/mg to $5.00/mg, median $1.57/mg across 16 vendors (compare)
Our lab tests
None yet (how testing will work)
WhereStatus
United StatesNone of the four components is an FDA-approved drug, and no approved product combines them [1].
United KingdomNo UK-licensed medicine contains any of the four components [2][3][4][5].
European UnionNo medicine containing GHK-Cu, KPV, BPC-157 or TB-500 is authorized in the EU, according to EMA's central and Article 57 product data [6][7].
CanadaNo product containing GHK-Cu, KPV, BPC-157 or TB-500 appears in Health Canada's Drug Product Database [8].
AustraliaBPC-157 and TB-500 are Schedule 4 with Appendix D possession controls; GHK-Cu and KPV are not named, but the Poisons Standard lists copper compounds for human use in Schedule 4, except low-strength preparations [9].
Sport (WADA)BPC-157 (S0) and TB-500 (S2) are prohibited at all times; GHK-Cu and KPV are not named [10].
 Summaries of official sources, checked —. Rules change; follow the source links. Not legal advice.

We haven't published a full overview of KLOW blend (GHK-Cu + KPV + BPC-157 + TB-500) yet. The legal status table and live prices on this page are current.

KLOW blend (GHK-Cu + KPV + BPC-157 + TB-500) prices: cheapest listings

The five lowest $/mg listings out of 18. See all KLOW blend (GHK-Cu + KPV + BPC-157 + TB-500) prices

Vendor Transparency Product Size Price $/mg vs median Stock Vendor's page
Bulk Peptide Supply 57/100* KLOW (KPV 10 MG, BPC-157 10 MG, TB-500 10 MG, GHK-CU 50 MG) 80 mg $45 $0.563/mg −64% In stock View
S1 Research 50/100 KLOW – GHK-CU 50mg /BPC-157 10mg /TB-500 10mg /KPV 10mg – 80mg 80 mg $50 $0.619/mg −61% In stock View
Royal Peptides FDA warning letter, Aug 2026 52/100 KLOW (GHK50mg + BPC-157 10mg + 10mg + TB-500 + KPV 10mg)80mgx10vials 80 mg × 10 $550 $0.688/mg −56% In stock View
Iron Aminos 40/100* KLOW Blend 80mg (BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg + KPV 10mg) 80 mg × 10 $595 $0.744/mg −53% In stock View
Bulk Peptide Supply 57/100* KLOW (KPV 10 MG, BPC-157 10 MG, TB-500 10 MG, GHK-CU 50 MG) 10 vials 80 mg × 10 $700 $0.875/mg −44% In stock View

Prices come from each vendor's public product feed and were last fetched Oct 15, 2026. They exclude shipping and discounts. $/mg uses the labeled amount, not measured content. A transparency score marked * is based on fewer than six checks; checks we couldn't complete score 0. How we compare prices.

Sources

  1. Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 14, 2026
  2. MHRA Products: licensed-medicine search for "ghk". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
  3. MHRA Products: licensed-medicine search for "kpv". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
  4. MHRA Products: licensed-medicine search for "bpc-157". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
  5. MHRA Products: licensed-medicine search for "thymosin". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
  6. EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 14, 2026
  7. EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 14, 2026
  8. Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 14, 2026
  9. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 14, 2026
  10. World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 14, 2026